2015
DOI: 10.1007/s40472-015-0079-0
|View full text |Cite
|
Sign up to set email alerts
|

Normothermic Ex Vivo Lung Perfusion in Clinical Lung Transplantation

Abstract: Normothermic ex vivo lung perfusion is a novel strategy of donor lung preservation that preserves the metabolic activity of the organ. There are therefore opportunities for further lung evaluation and therapeutic intervention during the ex vivo stage. We review our clinical experience with this technique and offer perspectives for future development.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0
1

Year Published

2021
2021
2023
2023

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(4 citation statements)
references
References 44 publications
0
3
0
1
Order By: Relevance
“…Initially, the Lund protocol was successfully performed with RBC containing perfusate. Subsequently, EVLP has been demonstrated with acellular perfusate as well 8 . Animal studies have also been performed to evaluate the physiological benefits of RBCs given their buffering action, rheology and oxygen-carrying capacity.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…Initially, the Lund protocol was successfully performed with RBC containing perfusate. Subsequently, EVLP has been demonstrated with acellular perfusate as well 8 . Animal studies have also been performed to evaluate the physiological benefits of RBCs given their buffering action, rheology and oxygen-carrying capacity.…”
Section: Discussionmentioning
confidence: 99%
“…The method described by the Toronto EVLP group was followed for initiation of perfusion, target flows, ventilation strategy and recruitment manoeuvre 8 . Briefly, the lungs were initially perfused through the left atrial cannula to remove debris.…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…Несмотря на развитие технологии и совершенствование протоколов иммуносупрессивной терапии, долгосрочная выживаемость реципиентов легких остается самой низкой среди всех трансплантаций солидных органов [12,15]. Причиной тому является высокая восприимчивость трансплантированных легких к воздействию как внешних, так и внутренних негативных факторов [9]. Это же обстоятельство актуально и для легких потенциального донора на этапе кондиционирования.…”
Section: Discussionunclassified